Irisbond Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
39
- Latest Deal Type
-
Later Stage VC
- (Cancelled)
- Latest Deal Amount
-
$5.8M
- Investors
-
7
Irisbond General Information
Description
Developer of a system-based eye-tracker designed for humans to communicate based on precision eye-tracking technology. The company's device is an infrared-based eye-tracking device that is used to control the eye moments of the affected patients, enabling them to regain the ability to communicate.
Contact Information
Website
www.irisbond.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Primary Office
- Avenida de Tolosa
- 75. Floor 2
- 20018 Donostia San-Sebastián
- Spain
+34 943 00 00 00
Irisbond Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | $5.8M | Cancelled | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 01-Aug-2018 | 00.00 | 00.000 | 00.00 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A) | 20-Apr-2015 | $346K | $412K | 00000 | Completed | Generating Revenue |
| 1. Seed Round | 23-Jun-2013 | $65.8K | $65.8K | Completed | Startup |
Irisbond Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| Preference | 00,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Irisbond Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Irisbond Patents
Irisbond Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3893090-A1 | Method for eye gaze tracking | Active | 09-Apr-2020 | 000000000 | 0 |
| EP-3893090-B1 | Method for eye gaze tracking | Active | 09-Apr-2020 | 000000000 | |
| ES-2925382-T3 | Gaze tracking method | Active | 09-Apr-2020 | 000000000 | |
| EP-3859491-A1 | Eye-tracker, system comprising eye-tracker and computer device and method for connection between eye-tracker and computer device | Pending | 29-Jan-2020 | 000000000 | 0 |
| US-20230073524-A1 | Eye-tracker, system comprising eye-tracker and computer device and method for connection between eye-tracker and computer device | Pending | 29-Jan-2020 | G06F3/038 |
Irisbond Executive Team (4)
Irisbond Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Fernando De Miguel | Irisbond | Board Member | 000 0000 |
| Santiago Descarrega | Fitalent | Secretary of the Board of Directors | 000 0000 |
Irisbond Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Irisbond Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Business Factory Auto | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| Geroa Pentsioak | Corporation | Minority | 000 0000 | 000000 0 | |
| Orza Investments | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Basque Venture Capital Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Everis Group | Corporation | Minority | 000 0000 | 000000 0 |